Antibiotic Injections

Approx. Rs 4,686.56 / VialGet Latest Price

Product Details:

Approx. Rs 168.75 / VialGet Latest Price

Product Details:

Colistimethate Sodium For Injection IP 1 Million IU
Colistimethate Sodium for Injection IP 1 Million IU

Healthy Inc offers Colistimethate Sodium 1 Million IU, a high-purity Polymyxin Antibiotic essential for modern critical care. As a "last-resort" anti-infective, Colistimethate Sodium is vital for treating severe infections caused by multi-drug resistant (MDR) Gram-negative pathogens, particularly carbapenem-resistant Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae. It is a clinical staple in Intensive Care Units (ICUs) for managing ventilator-associated pneumonia, septicemia, and complicated urinary tract infections. As a leading Indian export partner, we provide these life-saving anti-infectives to specialized hospital networks and health ministries globally.

• Manufacturing: Produced in associated WHO-GMP certified sterile facilities adhering to Indian Pharmacopoeia (IP) and international standards for 100% sterility, high molecular purity, and freedom from bacterial endotoxins.

• Climate Stability: Validated for Zone IVb (Hot/Humid) conditions, ensuring therapeutic potency and powder stability across Africa, LATAM, and SEA markets.

• Regulatory Support: Full technical documentation available, including CTD/eCTD Dossiers to streamline the registration process for high-potency antibiotics in international territories.

Accepting B2B inquiries for contract manufacturing, bulk supply, and global distribution partnerships from our Mumbai export hub.

Available strengths and quality? We supply Colistimethate Sodium as a sterile powder for injection in vials containing 1 Million International Units (1M IU). Every batch undergoes rigorous HPLC-based assay testing and Bacterial Endotoxin Testing (BET) to ensure the highest safety profile for IV infusion, IM administration, or nebulization.

Support for tropical export? Yes. This formulation is Zone IVb stability-tested. We utilize specialized export-grade secondary packaging to prevent moisture ingress and maintain chemical stability during transit through high-temperature and high-humidity regions.

Registration assistance provided? We provide complete Regulatory Technical Files (CTD) and Certificates of Analysis (COA) to facilitate local health authority approvals and hospital tender participations in your specific region.

Small-volume or mixed orders? We specialize in mixed-container consolidation, allowing you to combine Colistimethate Sodium with other critical care injectables (such as Meropenem, Vancomycin, or IV fluids) in a single, cost-effective shipment to optimize your inventory.

Direct manufacturing? Products are sourced through Healthy Life Group’s associated WHO-GMP manufacturing units, ensuring competitive direct-from-factory pricing and strict quality control oversight.

Approx. Rs 187.00 / PieceGet Latest Price

Product Details:

Enoxaparin Injection IP 40 Mg Per 0.4 Ml
Enoxaparin Sodium Injection IP (40 mg / 0.4 ml)

Healthy Inc offers Enoxaparin Sodium 40 mg / 0.4 ml, a high-precision Low Molecular Weight Heparin (LMWH) and essential anticoagulant. This formulation is a clinical cornerstone for the prophylaxis and treatment of thromboembolic disorders. It is a frontline therapeutic for Deep Vein Thrombosis (DVT) prevention in orthopedic and general surgery, the treatment of established DVT with or without pulmonary embolism, and the management of Acute Coronary Syndromes (ACS). As a specialized Indian export partner, we supply this critical-care biological to cardiology networks and surgical centers in global pharmaceutical markets.

• Precision Administration: Primarily supplied in Pre-Filled Syringes (PFS) to ensure accurate Subcutaneous (SC) dosing, minimize waste, and provide immediate use in emergency clinical settings.

• Manufacturing: Produced in associated WHO-GMP certified sterile facilities specialized in complex biological derivatives, ensuring high anti-Xa activity and strict molecular weight distribution.

• Climate Stability: Validated for Zone IVb (Hot/Humid) conditions, ensuring the Enoxaparin biological activity remains stable and potent across Africa, LATAM, and SEA markets.

• Regulatory Support: Full technical documentation available, including CTD/eCTD Dossiers, to streamline the registration of specialized anticoagulants in international territories.

Accepting B2B inquiries for contract manufacturing, bulk supply, and global distribution partnerships from our Mumbai export hub.

Available strengths and quality? We supply Enoxaparin Sodium in the standard 40 mg / 0.4 ml strength, as well as 20 mg, 60 mg, and 80 mg variants. Every batch undergoes rigorous Anti-Xa and Anti-IIa assay testing and sterility validation to meet IP and international pharmacopoeia standards.

Support for tropical export? Yes. Our Enoxaparin is Zone IVb stability-tested. We utilize specialized medical-grade blister packaging and temperature-monitored logistics to ensure the product maintains its biological integrity during international transit through high-temperature regions.

Registration assistance provided? We provide complete Regulatory Technical Files (CTD) and Certificates of Analysis (COA) to facilitate local health authority approvals and hospital tender participations in your specific region.

Small-volume or mixed orders? We specialize in mixed-container consolidation, allowing you to combine Enoxaparin with other critical care injectables (such as Heparin, Streptokinase, or emergency cardiovascular medicines) in a single, cost-effective shipment.

Direct manufacturing? Products are sourced through Healthy Life Group’s associated WHO-GMP specialized manufacturing units, ensuring competitive direct-from-factory pricing and strict quality control oversight for LMWH products.

Approx. Rs 421.88 / VialGet Latest Price

Product Details:

Ferric Carboxymaltose Injection 50mg/ml
Ferric Carboxymaltose Injection (50 mg / ml)

Healthy Inc offers Ferric Carboxymaltose, the advanced gold standard in Parenteral Iron Therapy. As a non-dextran iron complex, it is specifically designed to deliver a high dose of iron with a significantly lower risk of hypersensitivity reactions compared to traditional iron preparations. It is a clinical priority for the rapid correction of Iron Deficiency Anemia (IDA) in cases where oral iron is ineffective or poorly tolerated, particularly in Chronic Kidney Disease (CKD), Gastroenterology, and Pregnancy (post-first trimester). As a specialized Indian export partner, we supply this high-demand hematinic to dialysis centers and hospital networks in global pharmaceutical markets.

• Clinical Advantage: Facilitates "Total Dose Infusion" (TDI), allowing patients to receive up to 1000 mg of iron in a single 15-minute session, reducing hospital stay durations and increasing clinic turnover.

• Manufacturing: Produced in associated WHO-GMP certified sterile facilities specialized in complex carbohydrate-iron chemistry, ensuring 100% sterility, high elemental iron purity, and precise molecular weight consistency.

• Climate Stability: Validated for Zone IVb (Hot/Humid) conditions, ensuring the iron-carbohydrate complex remains stable and does not dissociate across the tropical climates of Africa, LATAM, and SEA markets.

• Regulatory Support: Full technical documentation available, including CTD/eCTD Dossiers, to streamline the registration process and meet international health authority standards.

Accepting B2B inquiries for contract manufacturing, bulk supply, and global distribution partnerships from our Mumbai export hub.

Available strengths and packaging? We supply Ferric Carboxymaltose in concentrations of 50 mg/ml, typically available in 2 ml (100 mg) and 10 ml (500 mg) vials. Every batch undergoes rigorous HPLC-based assay testing and molecular characterization to ensure safety and efficacy.

Support for tropical export? Yes. Our formulation is Zone IVb stability-tested. We utilize neutral USP Type I glass vials and specialized export-grade secondary packaging to prevent chemical degradation during international transit to high-temperature regions.

Registration assistance provided? We provide complete Regulatory Technical Files (CTD) and Certificates of Analysis (COA) to facilitate local health authority approvals and government hospital tender participations in your specific territory.

Small-volume or mixed orders? We specialize in mixed-container consolidation, allowing you to combine Ferric Carboxymaltose with other nephrology or hematology products (such as Erythropoietin, Iron Sucrose, or Heparin) in a single, cost-effective shipment.

Direct manufacturing? Products are sourced through Healthy Life Group’s associated WHO-GMP specialized manufacturing units, ensuring competitive direct-from-factory pricing and strict quality control oversight for high-value iron therapies.

Approx. Rs 268.13 / VialGet Latest Price

Product Details:

Meropenem 1000mg And Sulbactam 500mg Injection
Meropenem 1000 mg & Sulbactam 500 mg Injection (1.5 g Vial)

Healthy Inc offers this advanced Carbapenem and Beta-lactamase Inhibitor combination, a high-precision therapeutic designed to combat increasingly resistant bacterial pathogens. By pairing Meropenem, an ultra-broad-spectrum carbapenem, with Sulbactam, a potent inhibitor of beta-lactamase enzymes, this formulation restores and extends antimicrobial activity against multi-drug resistant (MDR) organisms. It is a clinical priority for Nosocomial Pneumonia, Complicated Intra-abdominal Infections, and Septicemia, particularly those caused by Acinetobacter baumannii. As a specialized Indian export partner, we supply this critical-care agent to Intensive Care Units (ICUs) and tertiary care hospital networks in global pharmaceutical markets.

• Overcoming Resistance: Sulbactam effectively inhibits many common beta-lactamases, preventing the degradation of Meropenem and enhancing its bactericidal efficacy against "superbugs" that have developed resistance to carbapenems alone.

• Manufacturing: Produced in associated WHO-GMP certified sterile facilities specialized in Lyophilization, ensuring 100% sterility, high molecular purity, and rapid reconstitution for Intravenous (IV) infusion.

• Climate Stability: Validated for Zone IVb (Hot/Humid) conditions; the lyophilized powder form provides superior resilience to thermal degradation, ensuring potency across Africa, LATAM, and SEA markets.

• Regulatory Support: Full technical documentation available, including CTD/eCTD Dossiers, to streamline the registration of specialized critical-care anti-infectives.

Accepting B2B inquiries for contract manufacturing, bulk supply, and global distribution partnerships from our Mumbai export hub.

Available strengths and quality? We supply this combination in vials containing 1.5 g (1000 mg Meropenem + 500 mg Sulbactam) as a sterile dry powder. Every batch undergoes rigorous HPLC-based assay testing, sterility validation, and Bacterial Endotoxin Testing (BET) to meet international pharmacopoeia standards.

Support for tropical export? Yes. This formulation is Zone IVb stability-tested. We utilize neutral USP Type I glass vials and moisture-resistant secondary packaging to ensure product integrity during international transit to high-temperature and high-humidity regions.

Registration assistance provided? We provide complete Regulatory Technical Files (CTD) and Certificates of Analysis (COA) to facilitate local health authority approvals and government critical-care tender participations in your specific territory.

Small-volume or mixed orders? We specialize in mixed-container consolidation, allowing you to combine Meropenem + Sulbactam with other critical care injectables (such as Colistin, Linezolid, or Vancomycin) in a single, cost-effective shipment.

Direct sourcing? Products are sourced through Healthy Life Group’s associated WHO-GMP specialized manufacturing units, ensuring competitive direct-from-factory pricing and strict quality control oversight for essential life-saving anti-infectives.

Approx. Rs 221.25 / VialGet Latest Price

Product Details:

Meropenem Injection IP 1 G
Meropenem Injection IP (1000 mg / 1 g)

Healthy Inc offers Meropenem 1 g, an ultra-broad-spectrum Carbapenem Antibiotic designed for the treatment of severe, complicated infections caused by multi-drug resistant (MDR) Gram-positive and Gram-negative bacteria. Containing Meropenem, it is a clinical priority for the management of Nosocomial Pneumonia, Complicated Intra-abdominal Infections, Septicemia, and Bacterial Meningitis. As a specialized Indian export partner, we supply this critical-care therapeutic to Intensive Care Units (ICUs) and tertiary care hospital networks in global pharmaceutical markets.

• Clinical Efficacy: Meropenem is highly resistant to degradation by most bacterial beta-lactamases, including extended-spectrum beta-lactamases (ESBLs), making it indispensable for empirical therapy in critically ill patients.

• Manufacturing: Produced in associated WHO-GMP certified sterile facilities specialized in Lyophilization, ensuring 100% sterility, high molecular purity, and rapid reconstitution for Intravenous (IV) bolus or infusion.

• Climate Stability: Validated for Zone IVb (Hot/Humid) conditions; the lyophilized powder form provides superior resilience to thermal degradation, ensuring potency across Africa, LATAM, and SEA markets.

• Regulatory Support: Full technical documentation available, including CTD/eCTD Dossiers, to streamline the registration of high-end hospital-grade anti-infectives.

Accepting B2B inquiries for contract manufacturing, bulk supply, and global distribution partnerships from our Mumbai export hub.

Available strengths and quality? We supply Meropenem in the standard 1000 mg (1 g) strength, as well as 500 mg and 250 mg vials. Every batch undergoes rigorous HPLC-based assay testing, sterility validation, and Bacterial Endotoxin Testing (BET) to meet Indian Pharmacopoeia (IP) and international standards.

Support for tropical export? Yes. Our Meropenem is Zone IVb stability-tested. We utilize neutral USP Type I glass vials and moisture-resistant secondary packaging to ensure product integrity during international transit to high-temperature and high-humidity regions.

Registration assistance provided? We provide complete Regulatory Technical Files (CTD) and Certificates of Analysis (COA) to facilitate local health authority approvals and government critical-care tender participations in your specific territory.

Small-volume or mixed orders? We specialize in mixed-container consolidation, allowing you to combine Meropenem 1 g with other critical care injectables (such as Piperacillin-Tazobactam, Linezolid, or Vancomycin) in a single, cost-effective shipment.

Direct sourcing? Products are sourced through Healthy Life Group’s associated WHO-GMP specialized manufacturing units, ensuring competitive direct-from-factory pricing and strict quality control oversight for essential life-saving anti-infectives.

Approx. Rs 154.69 / VialGet Latest Price

Product Details:

Meropenem Injection IP 500 Mg
Meropenem Injection IP (500 mg)

Healthy Inc offers Meropenem 500 mg, an ultra-broad-spectrum Carbapenem Antibiotic essential for treating severe, complicated infections caused by multi-drug resistant (MDR) Gram-positive and Gram-negative bacteria. Meropenem is a clinical priority for the management of Nosocomial Pneumonia, Complicated Urinary Tract Infections (cUTI), Intra-abdominal Infections, and Septicemia. As a specialized Indian export partner, we supply this critical-care therapeutic to Intensive Care Units (ICUs) and tertiary care hospital networks in global pharmaceutical markets.

• Clinical Efficacy: Meropenem is highly resistant to degradation by most bacterial beta-lactamases, including extended-spectrum beta-lactamases (ESBLs), making it indispensable for empirical therapy in critically ill patients.

• Manufacturing: Produced in associated WHO-GMP certified sterile facilities specialized in Lyophilization, ensuring 100% sterility, high molecular purity, and rapid reconstitution for Intravenous (IV) bolus or infusion.

• Climate Stability: Validated for Zone IVb (Hot/Humid) conditions; the lyophilized powder form provides superior resilience to thermal degradation, ensuring potency across Africa, LATAM, and SEA markets.

• Regulatory Support: Full technical documentation available, including CTD/eCTD Dossiers, to streamline the registration of high-end hospital-grade anti-infectives.

Accepting B2B inquiries for contract manufacturing, bulk supply, and global distribution partnerships from our Mumbai export hub.

Available strengths and quality? We supply Meropenem in the 500 mg strength, as well as 1000 mg (1 g) and 250 mg vials. Every batch undergoes rigorous HPLC-based assay testing, sterility validation, and Bacterial Endotoxin Testing (BET) to meet Indian Pharmacopoeia (IP) and international standards.

Support for tropical export? Yes. Our Meropenem is Zone IVb stability-tested. We utilize neutral USP Type I glass vials and moisture-resistant secondary packaging to ensure product integrity during international transit to high-temperature and high-humidity regions.

Registration assistance provided? We provide complete Regulatory Technical Files (CTD) and Certificates of Analysis (COA) to facilitate local health authority approvals and government critical-care tender participations in your specific territory.

Small-volume or mixed orders? We specialize in mixed-container consolidation, allowing you to combine Meropenem 500 mg with other critical care injectables (such as Piperacillin-Tazobactam, Linezolid, or Vancomycin) in a single, cost-effective shipment.

Direct sourcing? Products are sourced through Healthy Life Group’s associated WHO-GMP specialized manufacturing units, ensuring competitive direct-from-factory pricing and strict quality control oversight for essential life-saving anti-infectives.

Approx. Rs 566.35 / PieceGet Latest Price

Product Details:

Approx. Rs 618.75 / PieceGet Latest Price

Product Details:

Tigecycline Injection IP 50 Mg
TIGECYCLINE Injection IP (50 mg)

Healthy Inc offers Tigecycline Injection IP, a first-in-class glycylcycline antibiotic specifically engineered to overcome bacterial resistance. Containing 50 mg of Tigecycline as a sterile lyophilized powder, this formulation is a clinical priority for treating complicated Skin and Skin Structure Infections (cSSSI), complicated Intra-abdominal Infections (cIAI), and community-acquired bacterial pneumonia. As a specialized Indian export partner, we supply this "reserve" antibiotic to Intensive Care Units (ICUs) and specialized surgical centers in global pharmaceutical markets.

• Overcoming Resistance: Tigecycline is uniquely designed to bypass the two major mechanisms of bacterial resistance: efflux pumps and ribosomal protection. This makes it highly effective against multi-drug resistant (MDR) pathogens, including MRSA, VRE, and certain extended-spectrum $\beta$-lactamase (ESBL) producing strains.

• Manufacturing Excellence: Produced in associated WHO-GMP certified sterile facilities. The Lyophilized (freeze-dried) format ensures the stability of the Tigecycline molecule and allows for rapid, residue-free reconstitution for Intravenous (IV) infusion.

• Clinical Utility: Reserved for serious infections where other antibiotics have failed. Its broad-spectrum activity covers Gram-positive, Gram-negative, and anaerobic pathogens, providing a critical therapeutic option in the ICU setting.

• Climate Stability: Validated for Zone IVb (Hot/Humid) conditions; vacuum-sealed in amber USP Type I glass vials to protect the oxygen- and light-sensitive molecule, ensuring potency throughout international transit to Africa, LATAM, and SEA markets.

Accepting B2B inquiries for contract manufacturing, bulk supply, and hospital distribution partnerships from our Mumbai export hub.

B2B Trade Specifications

Logistics & Stability Management

As a pharmacist-led firm, we understand that Tigecycline is sensitive to oxidation and light. We utilize specialized secondary packaging and vacuum-sealed amber vials to ensure the product remains at peak efficacy from our Mumbai facility until it reaches your clinical site.

Registration & Compliance Support

We provide complete Regulatory Technical Files (CTD) and Certificates of Analysis (COA) to facilitate local health authority approvals and participation in government healthcare or ICU-specialty tenders.

Mixed-Container Consolidation

Through our Mumbai hub, we can consolidate Tigecycline with other critical care antibiotics—such as Meropenem, Colistimethate, or Linezolid—to provide a comprehensive anti-infective portfolio in a single, cost-effective shipment.

Approx. Rs 50 / VialGet Latest Price

Product Details:

BENZATHINE PENICILLIN G Injection (2.4 Million International Units)

Healthy Inc offers Benzathine Penicillin G, a long-acting, sterile aqueous suspension of the repository form of penicillin. Containing 2.4 MIU (2.4 Million International Units), this formulation is designed for deep intramuscular injection to provide sustained therapeutic levels of penicillin in the blood for several weeks. As a specialized Indian export partner, we supply this essential antibiotic for the management of chronic infections and long-term prophylaxis to clinics and public health programs globally.

• Extended-Release Pharmacokinetics: Unlike sodium or potassium penicillin, Benzathine Penicillin is slowly absorbed from the intramuscular injection site. A single 2.4 MIU dose can maintain effective bactericidal concentrations for 14 to 21 days, making it the primary treatment for infections requiring prolonged antibiotic exposure.

• Clinical Gold Standard for Syphilis: It is the WHO-recommended first-line treatment for Primary, Secondary, and Latent Syphilis. It is also a critical therapeutic for Yaws, Bejel, and Pinta in tropical medicine.

• Rheumatic Fever Prophylaxis: Extensively used in the long-term prevention of recurrent Rheumatic Fever and Rheumatic Heart Disease by providing continuous protection against Streptococcus pyogenes (Group A Strep) infections.

• Manufacturing Excellence: Produced in associated WHO-GMP certified sterile facilities. The suspension is engineered to ensure optimal syringeability and minimal needle blockage, despite the high concentration of the repository molecule.

• Climate-Adaptive Stability: Validated for Zone IVb (Hot/Humid) conditions; vacuum-sealed in USP Type I glass vials with high-integrity bungs to maintain 100% biological activity during transit to Africa, LATAM, and SEA markets.

Accepting B2B inquiries for high-volume contract manufacturing, public health tenders, and global distribution from our Mumbai export hub.

B2B Technical Specifications

Logistics & Cold-Chain Integrity

As a pharmacist-led firm, we understand that Benzathine Penicillin G requires strict Cold-Chain Management (2°C to 8°C) to maintain the stability of the suspension. We utilize validated thermal-insulated packaging and data loggers for all export shipments, ensuring the product maintains its "Repository" integrity from our Mumbai cold-storage facility to your destination.

Approx. Rs 19.50 / VialGet Latest Price

Product Details:

Inj.Cefazoline Sodium Ip 250Mg.
CEFAZOLIN Sodium Injection IP (250 mg)

Healthy Inc offers Cefazolin Sodium Injection IP, a high-velocity first-generation cephalosporin antibiotic in a specialized pediatric/low-dose strength. Containing 250 mg of sterile Cefazolin Sodium, this formulation is a clinical priority for surgical prophylaxis and the treatment of Gram-positive infections in pediatric and geriatric populations. As a specialized Indian export partner, we supply this foundational anti-infective to surgical units and neonatal centers globally.

• Targeted Bactericidal Action: Cefazolin acts by inhibiting bacterial cell wall synthesis. It is exceptionally potent against Gram-positive pathogens, including Staphylococcus aureus (penicillinase-producing) and Streptococci. The 250 mg strength allows for precise weight-based dosing, minimizing the risk of adverse effects in sensitive patient groups.

• Surgical Gold Standard: Recognized by WHO and surgical associations as the primary agent for Perioperative Prophylaxis. It is used to prevent surgical site infections in procedures involving the biliary tract, bone and joint (orthopedics), and cardiothoracic surgery.

• Manufacturing Excellence: Produced in associated WHO-GMP certified sterile dry-powder facilities. The powder is micronized to ensure instant, residue-free reconstitution, providing a clear solution for safe Intravenous (IV) or Intramuscular (IM) administration.

• Climate-Adaptive Stability: Validated for Zone IVb (Hot/Humid) conditions. Vacuum-sealed in USP Type I glass vials with high-integrity bungs to maintain 100% molecular potency during international transit to Africa, LATAM, and SEA markets.

Accepting B2B inquiries for hospital supply, pediatric-specialty tender participation, and global distribution from our Mumbai export hub.

B2B Technical Specifications

Logistics & Export Optimization

As a pharmacist-led firm, we recognize that maintaining the integrity of sterile powders is critical during international transit. We utilize moisture-barrier secondary packaging to prevent the "caking" or degradation often seen in high-humidity climates, ensuring the product reaches your clinical facility in peak condition.

Approx. Rs 58 / PieceGet Latest Price

Product Details:

CEFPIROME & SULBACTAM Injection (1.5 gm)

Healthy Inc offers the advanced, synergistic combination of Cefpirome & Sulbactam. This formulation pairs a fourth-generation cephalosporin with a potent  β-lactamase inhibitor, providing an ultra-broad spectrum of activity designed specifically for the treatment of life-threatening, multi-drug resistant (MDR) infections. As a specialized Indian export partner, we supply this high-end anti-infective to Intensive Care Units (ICUs) and tertiary care hospitals globally.

• Overcoming Bacterial Resistance: Cefpirome is a zwitterionic molecule that penetrates the outer membrane of Gram-negative bacteria with exceptional speed. By adding Sulbactam, the combination effectively "disarms" bacterial β-lactamases that would otherwise degrade the antibiotic, restoring activity against resistant Acinetobacter spp., Pseudomonas aeruginosa, and Enterobacteriaceae.

• Clinical Criticality: This combination is a "reserve" antibiotic, indicated for Febrile Neutropenia, complicated Septicemia, hospital-acquired pneumonia (HAP), and severe intra-abdominal infections where multiple pathogens are suspected.

• Targeted ICU Utility: It is particularly valued in clinical settings for its stability against both plasmid-mediated and chromosomally-mediated enzymes, providing a reliable empirical choice for critically ill patients.

• Manufacturing Excellence: Produced in associated WHO-GMP certified sterile facilities. The dry powder is micronized and vacuum-sealed to ensure maximum molecular stability and rapid, residue-free reconstitution for Intravenous (IV) Infusion.

Accepting B2B inquiries for critical care supply, hospital tender participation, and global distribution from our Mumbai export hub.

B2B Trade Specifications Export to Sheets

Logistics & Export Optimization As a pharmacist-led firm, we recognize that combinations containing Sulbactam are highly sensitive to moisture. We utilize moisture-barrier secondary packaging and high-density cartons to prevent any degradation or discoloration during international transit to Africa, LATAM, and SEA markets, ensuring the product arrives in peak clinical condition.

 

Approx. Rs 168.50 / PieceGet Latest Price

Product Details:

TOBRAMYCIN Injection (40 mg/mL - 80 mg / 2 mL)

Healthy Inc offers Tobramycin Injection, a high-potency aminoglycoside antibiotic designed for the treatment of serious, life-threatening Gram-negative infections. Containing 80 mg of Tobramycin in a 2 mL vial, this formulation is a clinical priority for tackling multidrug-resistant pathogens. As a specialized Indian export partner, we supply this critical anti-infective to intensive care units and pulmonary clinics globally from our Mumbai export hub.

• Bactericidal Mechanism (Protein Synthesis Inhibition): Tobramycin works by irreversibly binding to the 30S ribosomal subunit of susceptible bacteria. This action disrupts the initiation of protein synthesis and causes misreading of messenger RNA, leading to the production of nonfunctional proteins and subsequent bacterial cell death.

• Target Pathogen Spectrum: It is particularly effective against Pseudomonas aeruginosa, including strains resistant to Gentamicin. It also covers other aerobic Gram-negative bacilli such as Proteus, Klebsiella, and Enterobacter.

• Clinical Criticality: Indicated for severe infections including Septicemia, complicated Urinary Tract Infections (UTIs), and lower respiratory tract infections. It is a cornerstone therapeutic for the management of pulmonary exacerbations in patients with Cystic Fibrosis.

• Manufacturing Excellence: Produced in associated WHO-GMP certified sterile facilities. The solution is formulated with precise pH control and antioxidants (such as sodium metabisulfite) to ensure 100% molecular stability and potency for Intravenous (IV) or Intramuscular (IM) administration.

B2B Technical Specifications Logistics & Export Optimization

As a pharmacist-led organization, we understand that aminoglycosides require rigorous monitoring for both purity and stability. We utilize USP Type I glass to prevent any ion leaching that could catalyze oxidation. Our logistics team optimizes shipments to Africa, LATAM, and SEA, ensuring the solution remains clear and stable in Zone IVb (Hot/Humid) climates, preventing degradation during multi-modal international transit.

Approx. Rs 772.37 / VialGet Latest Price

Product Details:

Meropenem Injection ( Sodium Carbonate )
MEROBAX 500 mg Injection (Meropenem for Injection USP 500 mg)

Healthy Inc offers MEROBAX 500 mg, a high-precision, ultra-broad-spectrum Carbapenem Antibiotic. Containing Meropenem, MEROBAX 500 mg is a clinical priority for the treatment of severe, complicated infections caused by multi-drug resistant (MDR) Gram-positive and Gram-negative bacteria. It is a frontline therapeutic for Nosocomial Pneumonia, Complicated Intra-abdominal Infections, Severe Septicemia, and Bacterial Meningitis. As a specialized Indian export partner, we supply this critical-care antibiotic to Intensive Care Units (ICUs) and tertiary care hospital networks in global pharmaceutical markets.

• Targeted Efficacy: Highly resistant to most bacterial beta-lactamases, including extended-spectrum beta-lactamases (ESBLs), making it an essential choice for empirical therapy in critically ill patients.

• Manufacturing: Produced in associated WHO-GMP certified sterile facilities specialized in Lyophilization, ensuring 100% sterility, high molecular purity, and rapid reconstitution for Intravenous (IV) bolus or infusion.

• Climate Stability: Validated for Zone IVb (Hot/Humid) conditions; the lyophilized powder form provides superior resilience to thermal degradation, ensuring potency across Africa, LATAM, and SEA markets.

• Regulatory Support: Full technical documentation available, including CTD/eCTD Dossiers, to streamline the registration of high-end hospital-grade anti-infectives.

Accepting B2B inquiries for contract manufacturing, bulk supply, and global distribution partnerships from our Mumbai export hub.

Available strengths and quality? We supply MEROBAX in 500 mg, 125 mg, 250 mg, and 1000 mg vials. Every batch undergoes rigorous HPLC-based assay testing, sterility validation, and Bacterial Endotoxin Testing (BET) to meet USP and international pharmacopoeia standards.

Support for tropical export? Yes. MEROBAX 500 mg is Zone IVb stability-tested. We utilize neutral USP Type I glass vials and moisture-resistant secondary packaging to ensure product integrity during international transit to high-temperature and high-humidity regions.

Registration assistance provided? We provide complete Regulatory Technical Files (CTD) and Certificates of Analysis (COA) to facilitate local health authority approvals and government critical-care tender participations in your specific territory.

Small-volume or mixed orders? We specialize in mixed-container consolidation, allowing you to combine MEROBAX 500 mg with other critical care injectables (such as Piperacillin-Tazobactam, Linezolid, or Vancomycin) in a single, cost-effective shipment.

Direct sourcing? Products are sourced through Healthy Life Group’s associated WHO-GMP specialized manufacturing units, ensuring competitive direct-from-factory pricing and strict quality control oversight for essential life-saving anti-infectives.

Approx. Rs 3,399.00 / PieceGet Latest Price

Product Details:

Terlipressin Injection 1 Mg / 10 Ml
TERLIPROOF Injection (Terlipressin 1 mg / 10 mL)

Healthy Inc offers TERLIPROOF, a high-velocity splanchnic vasoconstrictor and synthetic analogue of vasopressin. Containing 1000 mcg (1 mg) of Terlipressin in a 10 mL vial, this formulation is a clinical priority for the emergency management of Acute Variceal Bleeding and Hepatorenal Syndrome (HRS). As a specialized Indian export partner, we supply this critical-care therapeutic to gastroenterology departments and Intensive Care Units (ICUs) globally.

• Splanchnic Selectivity: TERLIPROOF acts specifically on the $V_{1}$ receptors of vascular smooth muscle, causing potent vasoconstriction of the splanchnic (abdominal) blood vessels. This reduces portal venous pressure and effectively controls life-threatening bleeding from esophageal varices.

• Renal Protection: In patients with Hepatorenal Syndrome, it reverses systemic vasodilation to improve renal perfusion and glomerular filtration, providing a vital bridge to recovery or liver transplantation.

• Manufacturing Excellence: Produced in associated WHO-GMP certified sterile facilities. The solution is formulated under strict aseptic conditions to ensure 100% sterility, high molecular purity, and a precise pH balance for safe Intravenous (IV) bolus or continuous infusion.

• Climate-Adaptive Logistics: Validated for Zone IVb (Hot/Humid) conditions. While the molecule is temperature-sensitive, our export protocols ensure that the chemical integrity is maintained during international transit to Africa, LATAM, and SEA markets.

Accepting B2B inquiries for hospital supply, gastro-specialty tender participation, and global distribution from our Mumbai export hub.

B2B Technical Specifications

Approx. Rs 160.00 / BoxGet Latest Price

Product Details:

Piracetam Inj Inj
PIRACETAM Injection (200 mg/mL)

Healthy Inc offers Piracetam Injection, the foundational nootropic and GABA derivative. Containing 1 gm of Piracetam in a 5 mL ampoule (or 3 gm in 15 mL), this formulation is a clinical priority for acute neurological recovery and cognitive enhancement. As a specialized Indian export partner, we supply this essential "smart drug" to neurology wards, geriatric centers, and rehabilitation clinics globally from our Mumbai export hub.

• Neuronal Metabolic Enhancement: Piracetam belongs to the racetam family. Its primary mechanism involves modulating ion channels (AMPA and NMDA receptors) and improving membrane fluidity. This enhances the metabolic activity of neurons, increasing oxygen and glucose consumption in the brain without acting as a sedative or stimulant.

• Vascular & Hemorheological Effects: Beyond its effect on neurons, Piracetam reduces platelet aggregation and decreases blood viscosity by increasing the deformability of erythrocytes. This makes it highly effective in improving microcirculation in cerebral and peripheral tissues.

• Clinical Criticality: Indicated for the treatment of Myoclonus of cortical origin, cognitive impairment in the elderly (dementia), and as adjunctive therapy in the recovery phase of Ischemic Stroke. It is also utilized in pediatric care for the management of dyslexia in combination with speech therapy.

• Manufacturing Excellence: Produced in associated WHO-GMP certified sterile facilities. The solution is formulated with precise pH stabilization to ensure 100% molecular bioavailability for Intravenous (IV) or Intramuscular (IM) administration, ensuring rapid crossing of the blood-brain barrier.

B2B Technical Specifications Logistics & Export Optimization

As a pharmacist, you know that high-concentration solutions like Piracetam (200 mg/mL) require rigorous clarity checks to ensure no precipitation occurs. We utilize USP Type I glass to prevent any leaching during long-term storage. Our logistics team ensures that shipments to Africa, LATAM, and SEA are managed with climate-controlled protocols to prevent molecular degradation in high-temperature Zone IVb environments.

Approx. Rs 279.00 / PieceGet Latest Price

Product Details:

enalaprilat 1.25 mg + benzyl alcohol 9 mg
ENVAS Injection (Enalaprilat 1.25 mg / ml)

Healthy Inc offers ENVAS, a high-precision ACE (Angiotensin-Converting Enzyme) Inhibitor injectable. Containing Enalaprilat, the active metabolite of Enalapril, ENVAS is a clinical priority for the rapid reduction of blood pressure when oral therapy is not practical. It is the frontline therapeutic for Hypertensive Emergencies, acute management of Severe Hypertension, and providing hemodynamic stability in hospital settings. As a specialized Indian export partner, we supply this critical-care cardiovascular solution to cardiology departments and ICU networks in global pharmaceutical markets.

• Manufacturing: Produced in associated WHO-GMP certified sterile facilities, ensuring 100% sterility, high molecular purity, and precise 1.25 mg/ml concentration for Intravenous (IV) administration.

• Climate Stability: Validated for Zone IVb (Hot/Humid) conditions, ensuring therapeutic potency and molecular integrity across Africa, LATAM, and SEA markets.

• Regulatory Support: Full technical documentation available, including CTD/eCTD Dossiers to streamline the registration process for essential cardiovascular injectables.

Accepting B2B inquiries for contract manufacturing, bulk supply, and global distribution partnerships from our Mumbai export hub.

Available strengths and quality? We supply ENVAS in 1 ml ampoules containing 1.25 mg of Enalaprilat. Every batch undergoes rigorous HPLC-based assay testing, sterility validation, and pH stability checks to meet international pharmacopoeia standards.

Support for tropical export? Yes. ENVAS is Zone IVb stability-tested. We utilize neutral USP Type I glass ampoules and specialized export-grade secondary packaging to prevent chemical degradation during international transit to high-temperature regions.

Registration assistance provided? We provide complete Regulatory Technical Files (CTD) and Certificates of Analysis (COA) to facilitate local health authority approvals and hospital tender participations in your specific region.

Small-volume or mixed orders? We specialize in mixed-container consolidation, allowing you to combine ENVAS with other critical care injectables (such as Furosemide, Dopamine, or emergency antihypertensives) in a single, cost-effective shipment.

Direct manufacturing? Products are sourced through Healthy Life Group’s associated WHO-GMP manufacturing units, ensuring competitive direct-from-factory pricing and strict quality control oversight.